Cargando…
A Prognostic Model Using Inflammation- and Nutrition-Based Scores in Patients With Metastatic Gastric Adenocarcinoma Treated With Chemotherapy
The outcomes of patients with metastatic gastric cancer (mGC) are poor. Recent studies have identified the prognostic impact of inflammatory response and nutritional status on survival for patients with gastric cancer. This study aims to create a prognostic model using inflammatory- and nutrition-ba...
Autores principales: | Hsieh, Meng-Che, Wang, Shih-Hor, Chuah, Seng-Kee, Lin, Yu-Hung, Lan, Jui, Rau, Kun-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998719/ https://www.ncbi.nlm.nih.gov/pubmed/27124056 http://dx.doi.org/10.1097/MD.0000000000003504 |
Ejemplares similares
-
Development and validation of prognostic nomogram for patients with metastatic gastric adenocarcinoma based on the SEER database
por: Liu, Xianming, et al.
Publicado: (2023) -
D-Dimer Can Serve as a Prognostic and Predictive Biomarker for Metastatic Gastric Cancer Treated by Chemotherapy
por: Go, Se-Il, et al.
Publicado: (2015) -
The effects of hospice-shared care for gastric cancer patients
por: Huang, Kun-Siang, et al.
Publicado: (2017) -
Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy
por: Yoo, Shin Hye, et al.
Publicado: (2017) -
Durable response to immunotherapy plus chemotherapy in a patient with untreated, brain-metastatic, EGFR exon 20 insertion mutation lung adenocarcinoma: A case report
por: Nong, Jingying, et al.
Publicado: (2021)